FORWARD FEATURES CALENDAR

Deals

British Patient Capital invests in graphene-specialist Paragraf

British Patient Capital has participated in the USD60 million Series B funding round of Paragraf, a Cambridge-based graphene-based electronics company. This investment is being made through British Patient Capital’s Future Fund: Breakthrough programme, a GBP375 million initiative where British Patient Capital co-invests alongside private sector investors in later stage R&D-intensive

Blue Horizon makes California Cultured investment

Blue Horizon, a pure play impact investor in the future of food, has made its first investment in plant cell culture. Blue Horizon has invested in California Cultured, a Davis, California-based plant cell culture company pioneering a promising new application for cellular agriculture. Similar to cultivated meat, plant cell culture

Investor Group led by Advent International and Permira completes acquisition of McAfee

McAfee Corp, a specialist in online protection, has been acquired by an investor group led by Advent International Corporation (Advent) and funds advised by Permira, Crosspoint Capital Partners (Crosspoint), Canada Pension Plan Investment Board (CPP Investments), GIC Private Limited (GIC), and a wholly-owned subsidiary of the Abu Dhabi Investment Authority

AbbVie acquires Novo Holdings portfolio company Syndesi

Syndesi Therapeutics (Syndesi), a portfolio company of international life sciences investor Novo Holdings, has been acquired by AbbVie for up to USD1 billion in total deal value with USD130 million upfront. Syndesi was created in 2018 as the result of a close collaboration between Novo Seeds, the company creation arm

Sembly AI raises seed round led by MI-GSO | PCUBED

Sembly AI continues to consolidate its position as a provider of best-in-class conversation analytics for enterprise operations and technology teams through a new strategic partnership with MI-GSO | PCUBED, a project management and PMO consultancy. The partnership includes an investment in Sembly AI as well as a synergistic collaboration combining

TowerBrook to sell Orchid Insurance to Brown & Brown

The financial backers of Orchid Underwriters Agency, a specialty underwriter of catastrophe-exposed property insurance, led by TowerBrook Capital Partners are to sell the company to Brown & Brown, an insurance brokerage firm. The sale comprises all of Orchid’s Managing General Underwriter (MGU) and wholesaling business, along with its High-Net-Worth segment

Ropes & Gray advises Sezzle on acquisition by Zip Co

Ropes & Gray has advised Sezzle Inc on its acquisition by Zip Co. The transaction is expected to close in the third quarter of 2022. The agreement was announced on 28 February in a press release. Sezzle stockholders will be entitled to receive 0.98 Zip ordinary shares for every share

Riverside Company invests in ESHA Research

The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in ESHA Research (ESHA), a provider of SaaS-based nutritional analysis, labeling compliance and product formulation software. ESHA is trusted by food and beverage manufacturers, foodservice companies, health and wellness organizations, supplements manufacturers

Events

12 November, 2026 – 5:00 pm

Directory Listings